Researchers have used epigenetic editing to silence PCSK9. This gene-silencing system uses a modified version of CRISPR to add methyl groups to the PCSK9 gene, turning it off.
Publishing their findings in Nature Medicine, the researchers report the one-time treatment for high cholesterol in transgenic mice with human PCSK9 genes, and non-human primates.
News Medical Life Sciences has more.